Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,433 | 265 | 99.7% |
| Education | $15.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,075 | 70 | $0 (2024) |
| Amgen Inc. | $1,032 | 97 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $515.13 | 27 | $0 (2024) |
| PFIZER INC. | $392.50 | 12 | $0 (2024) |
| Lilly USA, LLC | $274.45 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $161.36 | 9 | $0 (2024) |
| GENZYME CORPORATION | $159.68 | 4 | $0 (2024) |
| Galderma Laboratories, L.P. | $147.09 | 3 | $0 (2024) |
| UCB, Inc. | $141.46 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $127.20 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,080 | 56 | ABBVIE INC. ($273.62) |
| 2023 | $777.57 | 42 | ABBVIE INC. ($281.81) |
| 2022 | $874.81 | 48 | ABBVIE INC. ($226.81) |
| 2021 | $451.62 | 29 | AbbVie Inc. ($180.07) |
| 2020 | $267.59 | 26 | Amgen Inc. ($148.74) |
| 2019 | $459.73 | 27 | Amgen Inc. ($144.01) |
| 2018 | $422.03 | 25 | Amgen Inc. ($135.83) |
| 2017 | $114.20 | 13 | Amgen Inc. ($114.20) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.76 | General |
| Category: Immunology | ||||||
| 11/14/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $13.85 | General |
| 11/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 10/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: Inflammation | ||||||
| 10/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $83.03 | General |
| 10/24/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $70.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,085 | 6,325 | $428,086 | $267,298 |
| 2022 | 27 | 3,228 | 6,284 | $443,910 | $278,252 |
| 2021 | 27 | 3,009 | 5,613 | $387,548 | $248,285 |
| 2020 | 17 | 2,690 | 4,649 | $312,156 | $199,581 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 832 | 1,235 | $112,000 | $73,202 | 65.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 334 | 422 | $48,719 | $30,953 | 63.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 135 | 228 | $39,130 | $27,775 | 71.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 490 | 649 | $44,199 | $24,011 | 54.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 55 | 60 | $18,543 | $13,723 | 74.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 403 | 2,738 | $18,550 | $13,259 | 71.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 105 | 140 | $17,398 | $10,470 | 60.2% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 28 | $12,117 | $8,157 | 67.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 145 | 177 | $10,063 | $6,679 | 66.4% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 83 | 85 | $10,098 | $5,987 | 59.3% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 53 | 63 | $8,787 | $5,930 | 67.5% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 22 | 26 | $8,363 | $5,848 | 69.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 47 | 60 | $14,907 | $5,618 | 37.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 18 | 22 | $6,920 | $5,302 | 76.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 78 | 78 | $8,787 | $4,923 | 56.0% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 43 | 53 | $7,410 | $4,747 | 64.1% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 46 | 58 | $7,265 | $4,223 | 58.1% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 24 | 31 | $8,422 | $3,228 | 38.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 22 | 30 | $7,687 | $3,119 | 40.6% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 49 | 55 | $5,679 | $2,605 | 45.9% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 20 | $2,838 | $2,058 | 72.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 14 | $3,967 | $1,555 | 39.2% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $1,914 | $1,409 | 73.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 20 | 20 | $2,066 | $1,296 | 62.7% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 20 | 21 | $2,259 | $1,219 | 54.0% |
About Dr. Kathryn Hansen, MD
Dr. Kathryn Hansen, MD is a Dermatology healthcare provider based in Kalispell, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770659518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathryn Hansen, MD has received a total of $4,448 in payments from pharmaceutical and medical device companies, with $1,080 received in 2024. These payments were reported across 266 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,433).
As a Medicare-enrolled provider, Hansen has provided services to 12,012 Medicare beneficiaries, totaling 22,871 services with total Medicare billing of $993,416. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Kalispell, MT
- Active Since 11/24/2006
- Last Updated 07/31/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1770659518
Products in Payments
- SKYRIZI (Biological) $619.93
- Enbrel (Biological) $554.12
- Otezla (Drug) $523.70
- RINVOQ (Biological) $322.00
- EUCRISA (Drug) $276.10
- TALTZ (Drug) $274.45
- COSENTYX (Drug) $244.12
- COSENTYX (Biological) $236.03
- DUPIXENT (Biological) $186.31
- Sotyktu (Drug) $161.36
- Bimzelx (Biological) $101.23
- DUPIXENT (Drug) $100.57
- HUMIRA (Biological) $81.77
- AMELUZ (Drug) $73.74
- LITFULO (Drug) $70.44
- OPZELURA (Drug) $68.38
- DUOBRII (Drug) $53.77
- Humira (Biological) $51.44
- ORACEA (Drug) $47.86
- REMICADE (Biological) $45.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Kalispell
Ann Brewer, M.d, M.D
Dermatology — Payments: $4,738
Thomas George, Md, MD
Dermatology — Payments: $1,208
Sylvia Owen, Md, MD
Dermatology — Payments: $769.66
Ellen Franciosi, Md, MD
Dermatology — Payments: $85.94
George Mclean, Md, MD
Dermatology
David Murdock, Md, MD
Dermatology